Strides Pharma Science Ltd.

₹1,195.7

8.3 (0.7%)

STAR Share Price

Pharmaceuticals & Biotechnology

As on September 9, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 11,076 Cr

P/E Ratio19.82

Dividend Yield0.04 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,135.02	Bullish
10-DMA	1,077.5	Bullish
20-DMA	1,028.4	Bullish
50-DMA	1,041.5	Bullish
100-DMA	1,066.73	Bullish
200-DMA	982.96	Bullish

Historical Performance

1 Year

36.1%

3 Years

148.7%

5 Years

100.6%

10 Years

21.6%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	48,587	45,653	38,901	36,884	30,702
Total Expenditure	40,141	37,676	33,179	33,031	30,918
Other Income	2,314	638	498	1,352	1,334
Operating Profit	10,760	8,615	6,221	5,205	1,119
Interest	1,785	2,489	2,802	2,611	1,767
Depreciation	2,024	1,923	2,136	2,433	2,330
Profit Before Tax	6,687	4,869	-1,148	-2,862	-6,525
Consolidated Net Profit	5,562	35,935	-706	-2,026	-4,602
Adjusted EPS	60	390	-8	-22	-51

Compounded Sales Growth

10 Years:11.2

5 Years:7.9

3 Years:5.7

TTM:1.3

Compounded Profit Growth

10 Years:38.7

5 Years:15.7

3 Years:-1

TTM:-31.1

Stock Price CAGR

10 Years:2

5 Years:14.9

3 Years:35.5

TTM:37.1

Return on Equity

10 Years:44.7

5 Years:-51.3

3 Years:-7.7

last year:60.3

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	922	922	919	903	898
Total Reserves	30,148	24,592	20,306	21,025	22,670
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	5,985	6,016	6,214	12,103	9,657
Other Current Liabilities	4,017	3,074	3,416	5,279	6,972
Short Term Borrowings	10,393	11,364	15,742	13,308	14,965
Total Liabilities	66,434	57,796	55,724	63,734	67,607
Capital Work in Progress	1,611	996	799	483	562
Long Term Loans & Advances	1,637	1,402	2,561	2,172	2,106
Currents Investments	---	695	1,058	508	---
Short Term Loans and Advances	1,549	1,359	1,750	1,533	1,455
Total Current Assets	36,128	30,989	29,690	31,352	33,618
Total Assets	66,434	57,796	55,724	63,734	67,607
Adjusted Book Value	337	277	231	243	262

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a moderate PE of 19.82, suggesting fair valuation relative to earnings.
Over the last three years, the stock delivered a strong 3-year price CAGR of 36.3%, indicating sustained price appreciation.
The stock carries a low beta of 0.6, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹10760 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹48587 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1370508.3

No. of Shares: 1146 (Approx)

Performance:37.1%

370508.3

NIFTY Performance: -6.2%

1 day Top Gainers